Race Investor Update March 2021
Race updates its Three Pillar Strategy, detailing intended programs and activitiesThe update confirms progress on…
Welcome to our Investor page. Here you will find information on the latest ASX announcements, investor presentations and other shareholder information on Race Oncology.
ASX Announcements
Share Price
Latest News
Race Initiates Extramedullary AML Preclinical Study
Race enters a collaborative preclinical research program with The University of Newcastle to support the…
Race Initiates FTO-Directed Kidney Cancer Preclinical Study
Race enters a collaborative preclinical research program with The University of Newcastle to explore use…
Race Initiates FTO Melanoma Preclinical Study
Race enters collaborative preclinical research program with The University of Newcastle to explore use of…
Compelling Preclinical Breast Cancer Results
Race Oncology Limited (ASX: RAC) is pleased to share the final results of our collaborative…
Positive Early Preclinical Ovarian Cancer Results
Bisantrene found to be more effective compared to doxorubicin and epirubicin in ovarian cancer cell…
